To overcome this immune-suppressive TME, TME modulation involved with TGF-β, PGE2, and IDO cytokines and NK cell activation using IL-2, IL-12, IL-18, and IFN-γ have been actively studied for the augmentation of NK cell cytotoxicity against tumor cells in TME [47]. This evidence concerns the gene IFNG and neoplasm.